Press release
Long Acting Drug Delivery Market Trend Report 2022-2031 by Top Area - Neurology, Oncology, Cardiovascular, Gastric, Ophthalmology
The Long Acting Drug Delivery Market is slated to witness exponentiation going forward. The IoMT (Internet-of-Medical-Things) is already transforming every walk of life, including healthcare. Healthcare IT has let both - patients and doctors carry/download information about each other anywhere and anytime through their smartphones/tabs. In other words, more connectivity translates to better access to data, thereby rendering better healthcare for patients. This would be the future of the healthcare vertical in the upcoming period.According to the latest research by PMR, long acting drug delivery systems are set to witness a steady-paced growth of CAGR 6.4% during the year 2021-2031.
Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders.
Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32863
The long acting drug delivery industry is expected to witness a rise in demand over the forecast period owing to the increasing technological advancements in clinical and pharmaceutical research globally.
The long acting drug delivery systems, such as implants and injectables are responsible for a controlled delivery of API in the patient's body. This is a major driving factor for the adoption of long acting drug delivery systems, as they reduce the burden of compliance on the patients, as compared to frequent dosing associated with traditional pills or injections.
The long acting drug delivery also reduces the metabolic degradation of the active pharmaceutical products by delivering targeted drug dosage directly into the environment or the bloodstream. The efficiency of such systems is thus responsible for driving the growth of long acting drug delivery systems worldwide.
Apart from great therapeutic effects of long acting drug delivery, the main augmentative factor in this industry is the increasing value of reformulated active pharmaceutical ingredients. The key players in the industry focus on patented formulations with specified dosage forms for the therapeutic treatment of several chronic diseases.
The increasing revenue as well as a unique stance in the market over the other players has led to intensive research through competition. Companies benefit from novel formulations because of their high revenue potential. This is set to augment the growth and development of long acting drug delivery systems over the forecast period.
The region of North America is expected to grow pose a dominant stance over the forecast period in terms of revenue share of long acting drug delivery systems. The factors aiding this growth are the presence of high profile, key players in the region, such as Lubrizol Life Science in the U.S., and innovation and development of new drug formulations.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32863
Additionally, many companies in this region are involved in strategic partnerships for enhancement of their product portfolios through research and development activities. For instance, in June 2021, ViiV Healthcare and Halozyme Therapeutics entered a global partnership and licence agreement to leverage the latter's ENHANZE drug delivery technology to develop 'ultra long-acting' drugs for human immunodeficiency virus (HIV).
The European region is expected to witness an increasing demand for long acting drug delivery systems. This is owed by the rising adoption of studies assessing the efficiency of these systems for their therapeutic effects.
For instance, long acting drug delivery implants, such as the thermoplastic polyurethanes (TPU), is used in an approved vaginal ring in Europe. It offers high levels of customization and control over drug release, creating possibilities for more efficient vaginal ring and implant designs.
The key companies operating in manufacturing and supply of long acting drug delivery systems are,
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences Inc.
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Zordera
Creative Biolabs.
Key Segments
By Therapies
Device
Implant
Vaginal rings
Microarray patch
Gastric resident device
Parenteral Injections
Monoclonal antibody
Polymer microsphere
In-situ forming gel
Oil depot
Aqueous dispersion
By Therapeutic Area
Neurology
Oncology
Cardiovascular
Gastric
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacies
Institutional Sales
Retail Sales
Clinical Research Institutes
Online Distribution Channels
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32863
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Long Acting Drug Delivery Market Trend Report 2022-2031 by Top Area - Neurology, Oncology, Cardiovascular, Gastric, Ophthalmology here
News-ID: 2796341 • Views: …
More Releases from Persistence Market Research
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview:
The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period.
Market Size and Growth:
The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and…
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction
Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities.
Get Access To…
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview:
The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033.
The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an…
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products.
To obtain the latest market…
More Releases for Therapeutic
HOME THERAPEUTIC EQUIPMENT INDUSTRY OUTLOOK 2022
The global home therapeutic equipment market is projected to grow from USD 11.06 billion in 2018 to USD XX.XX billion by 2030, at a CAGR of 5.5% during the forecast period. The growth of this market can be attributed to the increasing prevalence of chronic diseases, the rising geriatric population, and the growing demand for home healthcare services.
Get free copy of the report 2022: https://www.accuracyreports.com/request/download/12/11431/Global-Home-Therapeutic-Equipment-Industry-Outlook-2022:-Overview-Opportunities-Key-Companies-and-Forecast-to-2028
This report studies the Home Therapeutic…
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies…
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION
The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system…
Therapeutic Vaccines Market Insights by Top Players Novartis AG, GlaxoSmithKline …
Vaccine is a biological product that initiates stimulation to antibodies and helps provide immunity against infectious and chronic diseases. There are various types of vaccines such as inactivated vaccines, subunit vaccines, recombinant vector vaccines and DNA vaccines. Vaccines are mainly prophylactic in nature along with therapeutic effect. The wide application of vaccines is expected to favor the therapeutic vaccines market. Therapeutic vaccine is a combination of biologics that is designed…
Therapeutic Socks Market
Therapeutic Socks Market Overview
Compression therapy is a safe and cost-effective method of treating wounds, vein thrombosis, phlebitis and providing post-surgery care. It relies on a simple yet efficient principle – applying an elastic garment around a limb. A relatively new form of treatment, it is anticipated to post rapid growth during the next decade. Compression therapy includes garments like leggings, shirts, socks and stockings. The therapeutic socks market, otherwise known…
